Direct-Acting Antivirals against Hepatitis C

Direct-Acting Antivirals against Hepatitis C, 1st Edition, presents a dedicated academic reference on chronic hepatitis C management and direct-acting antiviral therapies. Designed for clinicians, researchers, practitioners, and advanced students specializing in hepatology and infectious diseases, this volume examines the fundamental biological mechanisms, clinical efficacy, and future potential of direct-acting antiviral interventions.

The text systematically reviews virus-host interactions, host-related determinants, intracellular signaling pathways, and established direct-acting antiviral drug classes. It analyzes comparative clinical efficacy data, treatment safety profiles, and patient tolerability across different therapeutic regimens, while assessing health benefits realized beyond initial virological response.

By incorporating expert scientific insights from specialists across immunology, pharmacology, virology, and clinical hepatology, this reference supplies grounded evidence to guide academic study and professional practice. The work provides practical analytical context for medical specialists and clinical research teams working to evaluate and optimize viral hepatitis treatment protocols.